Premium
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co‐transporter 2 inhibitors?
Author(s) -
Canepa Marco,
Ameri Pietro,
Lainscak Mitja
Publication year - 2021
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.2109
Subject(s) - dapagliflozin , medicine , heart failure , ejection fraction , comorbidity , copd , cardiology , placebo , stroke (engine) , intensive care medicine , diabetes mellitus , type 2 diabetes , endocrinology , mechanical engineering , engineering , alternative medicine , pathology